JIYA ACQUISITION CORP's ticker is JYAC and the CUSIP is 47760M102. A total of 59 filers reported holding JIYA ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $942,000 | +0.4% | 95,343 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $938,000 | +0.6% | 95,343 | 0.0% | 0.00% | – |
| Q4 2021 | $932,000 | 0.0% | 95,343 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $932,000 | -1.7% | 95,343 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $948,000 | -5.2% | 95,343 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $1,000,000 | -32.8% | 101,608 | -29.6% | 0.00% | 0.0% |
| Q4 2020 | $1,487,000 | – | 144,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 562,500 | $5,591,000 | 2.23% |
| Samsara BioCapital, LLC | 507,041 | $5,040,000 | 0.62% |
| Octagon Capital Advisors LP | 300,000 | $2,982,000 | 0.62% |
| Altium Capital Management LP | 200,000 | $1,988,000 | 0.46% |
| Consonance Capital Management LP | 300,000 | $2,982,000 | 0.36% |
| Bain Capital Life Sciences Investors, LLC | 300,000 | $2,982,000 | 0.20% |
| EcoR1 Capital, LLC | 500,000 | $4,970,000 | 0.19% |
| Boxer Capital, LLC | 500,000 | $4,970,000 | 0.18% |
| Cowen Investment Management LLC | 60,000 | $596,000 | 0.16% |
| GLAZER CAPITAL, LLC | 952,753 | $9,470,000 | 0.15% |